ArticleClinical cancer research : an official journal of the American Association for Cancer Research2018

Metabolic Reprogramming by Dual AKT/ERK Inhibition through Imipridones Elicits Unique Vulnerabilities in Glioblastoma.

Chiaki T Ishida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.